Abstract: Aspects of embodiments pertain to systems configured to perform neuromonitoring data analysis, by employing the following: receiving patient data comprising data that are descriptive of at least one physical stimulus applied to a mammalian subject for responsively generating at least one signal in a plurality of neural structures of the subject's nervous system; and sensor data descriptive of at least one neurophysiological response signal generated in response the applied physical stimulus. The systems are further configured to determine, based on the received patient data descriptive of the at least one physical stimulus and the generated response signal, at least one characteristic with respect to at least one of the plurality of neural structures of the patient.

Abstract: A manual intraosseous (IO) device for introducing a bone portal to a predetermined depth relative to a surface of a target bone, and methods for using same. The device is manually actuated and configured to limit the depth of penetration of a bone portal into a bone cortex independently of an applied driving force and independently of subcutaneous tissue thickness surrounding the bone cortex, while providing terminal feedback that the bone portal has been penetrated to the predetermined depth. The device has transfusion facilitating components that remain fixed at the penetration site following penetration of the bone portal to the predetermined depth and releasable components that are separated from the transfusion facilitating components prior to a transfusion operation. The device may also include a stabilizer, or base, that allows a health practitioner to easily locate the insertion site and allows low profile fixation of the IO transfusion component (IO catheter).

Abstract: A method of producing vitamin D is provided. The method comprising: (a) growing E. huxleyi under controlled UV-B radiation; and (b) dehydrating the E. huxleyi.

Abstract: A method of generating a digital signature. The method comprises calculating a first random number and, based on second and third random numbers, first and second modified versions thereof. A curve point on an elliptic curve is determined based on a base point and the first modified version. A first signature part is calculated based on the curve point. Based on the second and third random numbers, the modified versions of the first random number, data to be signed, the first signature part, and a private key, a second signature part and a check value for the second signature part are calculated. The second signature part is compared with the check value for the second signature part and, responsive to the check value for the second signature part matching the second signature part, a cryptographic signature is output comprising the first signature part and the second signature part.

Abstract: An overlay metrology system may include a controller for receiving metrology data associated with a plurality of overlay targets on one or more samples; generating a reference metric for at least some of the plurality of overlay targets based on the metrology data, where the reference metric is associated with one or more properties of the respective overlay targets that contributes to overlay error; classifying the plurality of overlay targets into one or more groups based on the reference metrics calculated for the plurality of overlay targets; generating a reference image for at least some of the one or more groups; generating corrected metrology data using the associated reference image for at least some of the one or more groups; and generating overlay measurements for the plurality of overlay targets based on the corrected metrology data.

Abstract: A benefit-provision system is operated by an administrator to provide a benefit from a source, which may be an administrator, to a benefit-eligible recipient who is part of or associated with a sponsored applicant group for which access to the benefit-provision system is being sponsored by a sponsor. A method thereof provides a benefit by an administrator from a source to a benefit-eligible recipient who is part of or associated with a sponsored applicant group for which access to a benefit-provision system is being sponsored by a sponsor.

Abstract: A method for analyzing a spectral signature of a compound specimen is provided. The method includes illuminating a compound specimen with a light in a predetermined spectrum; obtaining a spectral signature of the compound specimen, the spectral signature including at least one light property of a plurality of wavelengths in the spectrum transmitted through the compound specimen; extracting characterizing features of the spectral signature, the characterizing features being light properties of predetermined wavelengths within the spectrum; and comparing the characterizing features with corresponding features stored in a database, the corresponding features are corresponding properties of an expected spectral signature of a specimen including an examined substance.

Abstract: Methods of selecting umbilical cord blood units for ex-vivo expansion, separation of CD133+/CD34+ positive and uncultured CD133+/CD34+ negative fractions, methods for expanding the selected CD133+/CD34+ fraction, selection of expanded populations of CD133+/CD34+ cord blood cells for transplantation to subjects in need thereof and the therapeutic use of suitable selected, ex-vivo expanded CD133+/CD34+ and unselected CD133/CD34 negative cord blood fractions for transplantation in the clinical setting, for treatment of hematological malignancies are provided. The present invention also envisions kits comprising the expanded and unselected cord blood fractions.

Abstract: Embodiments of the invention relate to a method of indirect printing with an aqueous ink formulation applied to the surface of the intermediate transfer member. Related apparatus, systems and treatment formulations are disclosed herein.

Abstract: Methods of selecting umbilical cord blood units for ex-vivo expansion, separation of CD133+/CD34+ positive and uncultured CD133+/CD34+ negative fractions, methods for expanding the selected CD133+/CD34+ fraction, selection of expanded populations of CD133+/CD34+ cord blood cells for transplantation to subjects in need thereof and the therapeutic use of suitable selected, ex-vivo expanded CD133+/CD34+ and unselected CD133/CD34 negative cord blood fractions for transplantation in the clinical setting, for treatment of hematological malignancies are provided. The present invention also envisions kits comprising the expanded and unselected cord blood fractions.

Abstract: Disclosed are methods and devices that are useful for limiting plant growth using microwaves without the use of chemical agents such as herbicides and, in some embodiments, are thereby useful for weed control. Disclosed are also methods and devices that are useful for injuring and/or killing arthropods using microwaves without the use of chemical agents such as pesticides and, in some embodiments, are thereby useful for the control of arthropod infestation.

Abstract: There is provided a system and a method comprising obtaining data Dcontour informative of a contour of an element of a semiconductor specimen acquired by an examination tool, using the data Dcontour to generate a signal informative of a curvature of the contour of the element, determining at least one of data Dperiodicity informative of a periodicity of the signal, or data Ddiscontinuities informative of a number of discontinuities in the signal, wherein each discontinuity is informative of a transition between a convex portion of the contour and a concave portion of the contour, and using at least one of the data Dperiodicity or the data Ddiscontinuities to determine data informative of correct manufacturing of the element.

Abstract: There is provided a system and method of a method of detecting a local shape deviation of a structural element in a semiconductor specimen, comprising: obtaining an image comprising an image representation of the structural element; extracting, from the image, an actual contour of the image representation; estimating a reference contour of the image representation indicative of a standard shape of the structural element, wherein the reference contour is estimated based on a Fourier descriptor representative of the reference contour, the Fourier descriptor being estimated using an optimization method based on a loss function specifically selected to be insensitive to local shape deviation of the actual contour; and performing one or more measurements representative of one or more differences between the actual contour and the reference contour, the measurements indicative of whether a local shape deviation is present in the structural element.

Abstract: An imaging system is provided that includes a gantry, at least five detector units mounted to the gantry, a corresponding collimator for each of the detector units, at least one processing unit, and a controller. Each collimator has septa defining plural bores for each pixel of at least some of a plurality of pixels of the detector unit. A corresponding interior septum of the collimator is disposed above an internal portion of a corresponding pixel of the at least some of the plurality of pixels. The at least one processing unit is configured to obtain object information corresponding to the object to be imaged. The controller is configured to control an independent rotational movement of each the detector units used to acquire scanning information by detecting emissions from the object, wherein the controller rotates each of the detector units at a corresponding sweep rate.

Abstract: Embodiments of the invention relate to a method of indirect printing with an aqueous ink formulation applied to the surface of the intermediate transfer member. Related apparatus, systems and treatment formulations are disclosed herein.

Abstract: A system and method for non-invasively detecting abnormal electrical propagation in the heart are disclosed. The system and method include an interface for receiving a pacing signal applied to a heart of a patient, the pacing signal comprising (i) a sequence of regular pacing stimuli shorter than the sinus-rate intervals, and (ii) one or more extra pacing stimuli at intervals that are shorter than the regular pacing stimuli, a processor to assess the envelope of a body-surface ECG component after the regular pacing stimuli, assess the envelope of a body surface ECG component after the one or more extra pacing stimuli, and compare the assessed component after the extra pacing stimuli to the assessed component after the regular pacing stimuli. The interface outputting the comparison as an indication of regions of arrhythmogenicity and ablation targets in the heart.

Abstract: The present invention relates to transgenic grape cells, compositions comprising such cells or extracts or fractions thereof, and methods of use thereof for inhibiting or reducing the incidence of cytokine release syndrome or cytokine storm in a subject. Disclosed herein are also methods for preventing, treating, reducing the incidence, suppressing or inhibiting a coronavirus infection or a symptom thereof.

Abstract: A method of generating a digital signature. The method comprises calculating a first random number and, based on second and third random numbers, first and second modified versions thereof. A curve point on an elliptic curve is determined based on a base point and the first modified version. A first signature part is calculated based on the curve point. Based on the second and third random numbers, the modified versions of the first random number, data to be signed, the first signature part, and a private key, a second signature part and a check value for the second signature part are calculated. The second signature part is compared with the check value for the second signature part and, responsive to the check value for the second signature part matching the second signature part, a cryptographic signature is output comprising the first signature part and the second signature part.

Abstract: The present invention is directed to a commercial tomato, namely S. lycopersicum plant, which is resistant to an arthropod pest comprising in its genome introgressed sequences from S. galapagense conferring resistance to said arthropod pest, wherein the introgressed sequences are chosen from those present in the genome of a plant of the line TUT115 NCIMB accession number 42109. The commercial tomato of the invention is preferably resistant to ToMV (Tomato Mosaic Virus). The introgressed sequences are preferably found at one or more of the loci defined by the following SNP markers: SNP solcap_snp_sl_18619 on chromosome 1 and SNP solcap_snp_sl_12348 on chromosome 1.

Abstract: During end-to-end training of a Deep Neural Network (DNN), a differentiable estimator subnetwork is operated to estimate a functionality of an external software application. Then, during inference by the trained DNN, the differentiable estimator subnetwork is replaced with the functionality of the external software application, by enabling API communication between the DNN and the external software application.